In this study, we demonstrated that EMC2 was aberrantly upregulated in breast cancer tissues, significantly enhanced the proliferation and metastasis potential of tumor cells, and increased the sensitivity of tumor cells to PDK1/AKT inhibition. This evidence concerns the gene AKT1 and breast cancer.